1-7 of 7
Andrew Lewin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Erratum. Combination of Empagliflozin and Linagliptin as Second-Line Therapy in Subjects With Type 2 Diabetes Inadequately Controlled on Metformin. Diabetes Care 2015;38: 384–393

Ralph A. DeFronzo, Andrew Lewin, Sanjay Patel, Dacheng Liu, Renee Kaste, Hans J. Woerle, Uli C. Broedl
Journal: Diabetes Care
Diabetes Care 2015;38(6):1173
https://doi.org/10.2337/dc15-er06
Published: 12 May 2015
View article titled, Erratum. Combination of Empagliflozin and Linagliptin as Second-Line Therapy in Subjects With Type 2 Diabetes Inadequately Controlled on Metformin. Diabetes Care 2015;38: 384–393
Open the PDF for Erratum. Combination of Empagliflozin and Linagliptin as Second-Line Therapy in Subjects With Type 2 Diabetes Inadequately Controlled on Metformin. Diabetes Care 2015;38: 384–393 in another window
Journal Articles

Erratum. Initial Combination of Empagliflozin and Linagliptin in Subjects With Type 2 Diabetes. Diabetes Care 2015;38: 394–402

Andrew Lewin, Ralph A. DeFronzo, Sanjay Patel, Dacheng Liu, Renee Kaste, Hans J. Woerle, Uli C. Broedl
Journal: Diabetes Care
Diabetes Care 2015;38(6):1173
https://doi.org/10.2337/dc15-er06a
Published: 12 May 2015
View article titled, Erratum. Initial Combination of Empagliflozin and Linagliptin in Subjects With Type 2 Diabetes. Diabetes Care 2015;38: 394–402
Open the PDF for Erratum. Initial Combination of Empagliflozin and Linagliptin in Subjects With Type 2 Diabetes. Diabetes Care 2015;38: 394–402 in another window
Journal Articles

Initial Combination of Empagliflozin and Linagliptin in Subjects With Type 2 Diabetes

Andrew Lewin, Ralph A. DeFronzo, Sanjay Patel, Dacheng Liu, Renee Kaste, Hans J. Woerle, Uli C. Broedl
Journal: Diabetes Care
Diabetes Care 2015;38(3):394–402
https://doi.org/10.2337/dc14-2365
Published: 29 January 2015
View article titled, Initial Combination of Empagliflozin and Linagliptin in Subjects With Type 2 Diabetes
Open the PDF for Initial Combination of Empagliflozin and Linagliptin in Subjects With Type 2 Diabetes in another window
Includes: Supplementary data
Journal Articles

Combination of Empagliflozin and Linagliptin as Second-Line Therapy in Subjects With Type 2 Diabetes Inadequately Controlled on Metformin

Ralph A. DeFronzo, Andrew Lewin, Sanjay Patel, Dacheng Liu, Renee Kaste, Hans J. Woerle, Uli C. Broedl
Journal: Diabetes Care
Diabetes Care 2015;38(3):384–393
https://doi.org/10.2337/dc14-2364
Published: 12 January 2015
View article titled, Combination of Empagliflozin and Linagliptin as Second-Line Therapy in Subjects With Type 2 Diabetes Inadequately Controlled on Metformin
Open the PDF for Combination of Empagliflozin and Linagliptin as Second-Line Therapy in Subjects With Type 2 Diabetes Inadequately Controlled on Metformin in another window
Includes: Supplementary data
Journal Articles

Efficacy and Safety of the Human Glucagon-Like Peptide-1 Analog Liraglutide in Combination With Metformin and Thiazolidinedione in Patients With Type 2 Diabetes (LEAD-4 Met+TZD)

Bernard Zinman, MD, John Gerich, MD, John B. Buse, MD, PHD, Andrew Lewin, MD, Sherwyn Schwartz, MD, Philip Raskin, MD, Paula M. Hale, PHD, Milan Zdravkovic, PHD, Lawrence Blonde, MD, the LEAD-4 Study Investigators
Journal: Diabetes Care
Diabetes Care 2009;32(7):1224–1230
https://doi.org/10.2337/dc08-2124
Published: 16 March 2009
View article titled, Efficacy and Safety of the Human Glucagon-Like Peptide-1 Analog Liraglutide in Combination With Metformin and Thiazolidinedione in Patients With Type 2 Diabetes (LEAD-4 Met+TZD)
Open the PDF for Efficacy and Safety of the Human Glucagon-Like Peptide-1 Analog Liraglutide in Combination With Metformin and Thiazolidinedione in Patients With Type 2 Diabetes (LEAD-4 Met+TZD) in another window
Includes: Supplementary data
Journal Articles

Efficacy, Tolerability, and Safety of a Novel Once-Daily Extended-Release Metformin in Patients With Type 2 Diabetes

Sherwyn Schwartz, MD, Vivian Fonseca, MD, MRCP, Bret Berner, PHD, Marilou Cramer, Yu-Kun Chiang, PHD, Andrew Lewin, MD
Journal: Diabetes Care
Diabetes Care 2006;29(4):759–764
https://doi.org/10.2337/diacare.29.04.06.dc05-1967
Published: 01 April 2006
View article titled, Efficacy, Tolerability, and Safety of a Novel Once-Daily Extended-Release Metformin in Patients With Type 2 Diabetes
Open the PDF for Efficacy, Tolerability, and Safety of a Novel Once-Daily Extended-Release Metformin in Patients With Type 2 Diabetes in another window
Journal Articles

Initiating Insulin Therapy in Type 2 Diabetes : A comparison of biphasic and basal insulin analogs

Philip Raskin, MD, Elsie Allen, MD, Priscilla Hollander, MD, Andrew Lewin, MD, Robert A. Gabbay, MD, PHD, Peter Hu, PHD, Bruce Bode, MD, Alan Garber, MD, for the INITIATE Study Group
Journal: Diabetes Care
Diabetes Care 2005;28(2):260–265
https://doi.org/10.2337/diacare.28.2.260
Published: 01 February 2005
View article titled, Initiating Insulin Therapy in Type 2 Diabetes : <subtitle>A comparison of biphasic and basal insulin analogs</subtitle>
Open the PDF for Initiating Insulin Therapy in Type 2 Diabetes : <subtitle>A comparison of biphasic and basal insulin analogs</subtitle> in another window